Actively Recruiting

Age: 65Years - 74Years
All Genders
ID07486661

A Pilot Project for People Living with HIV Aged 65-75: Preventing the Development of Frailty

Led by Centre Hospitalier Universitaire Saint Pierre · Updated on 2026-03-20

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research focuses on people living with HIV (PLWH) aged 65 to 74, studying the development and prevention of frailty syndrome. Frailty involves multiple health issues, cognitive decline, and reduced physical reserves, leading to higher risks of hospitalizations and mortality. The study aims to understand how frailty affects this specific age group and validate a screening tool called the Fried scale in PLWH. Participants will be systematically screened using the Fried scale by a nurse before their physician visit. Those who screen positive for frailty risk will be referred for a specialized geriatric consultation to confirm their condition and receive a preventive care plan. After treatment, participants will complete a satisfaction questionnaire and undergo a follow-up Fried scale assessment one year later. Throughout the study, researchers will measure the number of PLWH aged 65 to 74 who have frailty or pre-frailty conditions at the start and one year later. The study involves regular screenings, consultations, and questionnaires to monitor participants' health and satisfaction with care. This observational study will run until July 2028, with no experimental treatments involved.

CONDITIONS

Brief Title

A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty

Who Can Participate

Age: 65Years - 74Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Living with HIV
  • Between 65 and 74 years old
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants undergo assessments to evaluate their frailty status using the Fried scale.

1 visit (in-person)

Long-term Monitoring

Duration - 1 year

Participants are monitored for changes in frailty status over one year after the initial assessment.

1 visit after 1 year (in-person)

Trial Site Locations

Total: 1 location

1

CHU Saint-Pierre, centre MIA

Brussels, Belgium, 1000

Actively Recruiting

Loading map...

Research Team

A

Agnes LIBOIS, MD

C

Charlotte Martin, MD, PHD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

#AWARE.HIV Europe: Supporting Healthcare Professionals to Fi...

HIV Infection

Actively Recruiting

28 locations

1MoreStep: Pilot Trial of an Intervention to Increase HIV Ca...

Violence, Domestic

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Prevalence of Frailty and Prefrailty in People With Human Immunodeficiency Virus Aged 50 or Older: A Systematic Review and Meta-Analysis.

Yuji Yamada, Takaaki Kobayashi, Angela Condo...

https://pubmed.ncbi.nlm.nih.gov/35415198